Integration of computer-aided automated analysis algorithms in the development and validation of immunohistochemistry biomarkers in ovarian cancer
- 19 November 2020
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 74 (7) , 469-474
Abstract
In an era when immunohistochemistry (IHC) is increasingly depended on for histological subtyping, and IHC-determined biomarker informing rapid treatment choices is on the horizon; reproducible, quantifiable techniques are required. This study aimed to compare automated IHC scoring to quantify 6 DNA damage response protein markers using a tissue microarray of 66 ovarian cancer samples. Accuracy of quantification was compared between manual H-score and computer-aided quantification using Aperio ImageScope with and without a tissue classification algorithm. High levels of interobserver variation was seen with manual scoring. With automated methods, inclusion of the tissue classifier mask resulted in greater accuracy within carcinomatous areas and an overall increase in H-score of a median of 11.5% (0%–18%). Without the classifier, the score was underestimated by a median of 10.5 (5.2–25.6). Automated methods are reliable and superior to manual scoring. Fixed algorithms offer the reproducibility needed for high-throughout clinical applications.Keywords
Funding Information
- Newcastle upon Tyne Hospitals NHS Charity (1057213)
This publication has 12 references indexed in Scilit:
- Correlations between RNA and protein expression profiles in 23 human cell linesBMC Genomics, 2009
- Image Analysis Algorithms for Immunohistochemical Assessment of Cell Death Events and Fibrosis in Tissue SectionsJournal of Histochemistry & Cytochemistry, 2009
- Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasmsPathology International, 2006
- Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic MarkersClinical Cancer Research, 2005
- Expression of progesterone receptor is a favorable prognostic marker in ovarian cancerGynecologic Oncology, 2005
- Further evaluation of reproducibility and prognostic value of histologic typing and grading in FIGO stage I ovarian cancer patients without systemic locoregional adjuvant treatmentInternational Journal of Gynecological Cancer, 1995
- Observer Disagreement in Histological Classification of Ovarian Tumors in JapanGynecologic Oncology, 1994
- Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancerInternational Journal of Gynecological Cancer, 1993
- Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implicationsAPMIS, 1991
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986